Global Multiplex PCR Assays Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Multiplex PCR Assays Market Insights, Forecast to 2034
Multiplex PCR, also known as multiplex primer PCR or multiplex PCR, is a PCR reaction in which more than two pairs of primers are added to the same PCR reaction system, and at the same time, multiple nucleic acid fragments are amplified The Reaction Reagent and the operation process are the same as the ordinary PCR. In general, PCR only uses a pair of primers and produces a nucleic acid fragment by PCR amplification, which is mainly used for the identification of single pathogenic factor.Multiplex PCR is mainly used to detect and identify some pathogenic microorganisms, some genetic diseases and genotyping of oncogenes.
Market Analysis and InsightsGlobal Multiplex PCR Assays Market
Global Multiplex PCR Assays market is expected to reach to US$ 1189 million in 2023, with a positive growth of %, compared with US$ 1103 million in 2022. Backed with the increasing demand from downstream industries, Multiplex PCR Assays industry is evaluated to reach US$ 1855.6 million in 2033. The CAGR will be 7.7% during 2023 to 2033.
Globally, Multiplex PCR Assays key companies include Abbott, Siemens, Roche, Agena Bioscience, BD, PerkinElmer, Luminex, QIAGEN and Agilent Technologies, etc. Abbott, Siemens, Roche are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Multiplex PCR Assays were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Multiplex PCR Assays market and estimated to attract more attentions from industry insiders and investors.
Multiplex PCR Assays can be divided into Products and Services, etc. Products is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Multiplex PCR Assays is widely used in various fields, such as Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes and Others, etc. Hospitals provides greatest supports to the Multiplex PCR Assays industry development. In 2022, global % revenue of Multiplex PCR Assays went into Hospitals filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Multiplex PCR Assays market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Multiplex PCR Assays market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Abbott
Siemens
Roche
Agena Bioscience
BD
PerkinElmer
Luminex
QIAGEN
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Seegene
Olink
Illumina
Bio-Rad Laboratories
Abcam
Quanterix
Segment by Type
Products
Services
Hospitals
Pharmaceutical & Biotechnology Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Multiplex PCR Assays introduction, etc. Multiplex PCR Assays Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Multiplex PCR Assays
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Multiplex PCR Assays Market
Global Multiplex PCR Assays market is expected to reach to US$ 1189 million in 2023, with a positive growth of %, compared with US$ 1103 million in 2022. Backed with the increasing demand from downstream industries, Multiplex PCR Assays industry is evaluated to reach US$ 1855.6 million in 2033. The CAGR will be 7.7% during 2023 to 2033.
Globally, Multiplex PCR Assays key companies include Abbott, Siemens, Roche, Agena Bioscience, BD, PerkinElmer, Luminex, QIAGEN and Agilent Technologies, etc. Abbott, Siemens, Roche are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Multiplex PCR Assays were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Multiplex PCR Assays market and estimated to attract more attentions from industry insiders and investors.
Multiplex PCR Assays can be divided into Products and Services, etc. Products is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Multiplex PCR Assays is widely used in various fields, such as Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes and Others, etc. Hospitals provides greatest supports to the Multiplex PCR Assays industry development. In 2022, global % revenue of Multiplex PCR Assays went into Hospitals filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Multiplex PCR Assays market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Multiplex PCR Assays market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Abbott
Siemens
Roche
Agena Bioscience
BD
PerkinElmer
Luminex
QIAGEN
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Seegene
Olink
Illumina
Bio-Rad Laboratories
Abcam
Quanterix
Segment by Type
Products
Services
Segment by Application
Hospitals
Pharmaceutical & Biotechnology Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Multiplex PCR Assays introduction, etc. Multiplex PCR Assays Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Multiplex PCR Assays
Chapter 13Methodology and Data Sources adopted by MRAResearch